Navigation Links
Growth in biomass could put US on road to energy independence

on foreign oil, a potential 10 percent reduction in greenhouse gas emissions and an improved rural economic picture.

Current production of ethanol is about 3.4 billion gallons per year, but that total could reach 80 billion gallons or more under the scenario outlined in this report. Such an increase in ethanol production would see transportation fuels from biomass increase from 0.5 percent of U.S. consumption in 2001 to 4 percent in 2010, 10 percent in 2020 and 20 percent in 2030. In fact, depending on several factors, biomass could supply 15 percent of the nation's energy by 2030.

Meanwhile, biomass consumption in the industrial sector would increase at an annual rate of 2 percent through 2030, while biomass consumption by electric utilities would double every 10 years through 2030. During the same time, production of chemicals and materials from bio-based products would increase from about 12.5 billion pounds, or 5 percent of the current production of target U.S. chemical commodities in 2001, to 12 percent in 2010, 18 percent in 2020 and 25 percent in 2030.

Nearly half of the 2,263 million acres that comprise the land base of the U.S. has potential for growing biomass. About 33 percent of the land area is classified as forest, 26 percent as grassland, 20 percent as cropland, 13 percent as urban areas, swamps and deserts, and 8 percent as special uses such as public facilities.

###

The report, titled "Biomass as Feedstock for a Bioenergy and Bioproducts Industry: The Technical Feasibility of a Billion-Ton Annual Supply," was sponsored by DOE's Office of Energy Efficiency and Renwable Energy, Office of Biomass Program. Lynn Wright and Anthony Turhollow of ORNL, Bryce Stokes of the USDA Forest Service and Don Erbach of the USDA Agriculture Research Service are co-authors of the report. The complete report is available at: http://feedstockreview.ornl.gov/pdf/billion_ton_vision.pdf.


'"/>

Source:DOE/Oak Ridge National Laboratory


Page: 1 2

Related biology news :

1. Growth in the sea comes down to a struggle for iron
2. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
3. Embryonic Stem Cells Treated With Growth Factor Reverse Hemophilia In Mice: UNC Researchers
4. Missing Receptor Molecule Causes Tumor Growth
5. Growth hormone is made in the brain, report scientists
6. Growth factor-promoting angiogenesis expressed in tumor cells and normal neurons
7. New Research Shows Artificial Light at Night Stimulates Breast Cancer Growth in Laboratory Mice
8. Growth factor stimulates rapid extension of key motor neurons in brain
9. Growth hormone to boost athletic performance risks diabetes
10. Growth hormone is not the anti-aging bullet for healthy adults
11. Protein discovery could unlock the secret to better TB treatment
Post Your Comments:
Breaking Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4
Other Biology Technology:Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results 2Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results 3Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results 4Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results 5Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results 6BMP Sunstone Reports Third Quarter 2008 Financial Results 2BMP Sunstone Reports Third Quarter 2008 Financial Results 3BMP Sunstone Reports Third Quarter 2008 Financial Results 4BMP Sunstone Reports Third Quarter 2008 Financial Results 5BMP Sunstone Reports Third Quarter 2008 Financial Results 6BMP Sunstone Reports Third Quarter 2008 Financial Results 7BMP Sunstone Reports Third Quarter 2008 Financial Results 8BMP Sunstone Reports Third Quarter 2008 Financial Results 9BMP Sunstone Reports Third Quarter 2008 Financial Results 10BMP Sunstone Reports Third Quarter 2008 Financial Results 11BMP Sunstone Reports Third Quarter 2008 Financial Results 12BMP Sunstone Reports Third Quarter 2008 Financial Results 13BMP Sunstone Reports Third Quarter 2008 Financial Results 14Endocare Reports Financial Results for Third Quarter 2008 2Endocare Reports Financial Results for Third Quarter 2008 3Endocare Reports Financial Results for Third Quarter 2008 4Endocare Reports Financial Results for Third Quarter 2008 5Endocare Reports Financial Results for Third Quarter 2008 6Endocare Reports Financial Results for Third Quarter 2008 7Endocare Reports Financial Results for Third Quarter 2008 8Endocare Reports Financial Results for Third Quarter 2008 9Endocare Reports Financial Results for Third Quarter 2008 10Endocare Reports Financial Results for Third Quarter 2008 11